Technology
Health
Biotechnology

Evofem

$5.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (1.63%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Evofem and other stocks, options, ETFs, and crypto commission-free!

About EVFM

Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. Read More The company was founded in 2007 and is headquartered in San Diego, CA.

Employees
30
Headquarters
San Diego, California
Founded
2007
Market Cap
141.26M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
44.18K
High Today
$5.08
Low Today
$4.92
Open Price
$4.92
Volume
31.75K
52 Week High
$7.24
52 Week Low
$1.79

Collections

Technology
Health
Biotechnology
2014 IPO
US
North America
Female CEOs

EVFM Earnings

-$1.11
-$0.86
-$0.62
-$0.37
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.